参考文献 References
[1] Rizk J G, Gupta A, Sardar P,et al. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia with Cerebral Venous Sinus Thrombosis: A Review [J]. JAMA Cardiol, 2021, 6(12):1451-1460.
[2] Algahtani H, Bazaid A, Shirah B,et al. Cerebral Venous Sinus Thrombosis in Pregnancy and Puerperium: A Comprehensive Review [J]. Brain Circ, 2022, 8(4):180-187.
[3] Mora R, Ibarra L, Olivera V,et al. Venous and Cerebral Sinus Thrombosis in Newborns and Children [J]. Medicina (B Aires), 2023, 83 Suppl 4:95-101.
[4] Kotowski M, Szydlowski J. Otogenic Cerebral Sinus Thrombosis in Children: A Narrative Review [J]. Neurol Ther, 2023, 12(4):1069-79.
[5] 安攀, 赵沙沙, 梁寿衡, 等. 3D-TOF MRA序列在颅内静脉窦血栓中的协助诊断价值 [J]. 中国CT和MRI杂志, 2023, 21(11):18-20.
[6] Ferro J M, Aguiar De Sousa D. Cerebral Venous Thrombosis: An Update [J]. Curr Neurol Neurosci Rep, 2019, 19(10):74.
[7] Triquenot Bagan A, Crassard I, Drouet L,et al. Cerebral Venous Thrombosis: Clinical, Radiological, Biological, and Etiological Characteristics of a French Prospective Cohort (FPCCVT)-Comparison with ISCVT Cohort [J]. Front Neurol, 2021, 12:753110.
[8] Geisbusch C, Herweh C, Gumbinger C,et al. Chronic Intracranial Hypertension After Cerebral Venous and Sinus Thrombosis - Frequency and Risk Factors [J]. Neurol Res Pract, 2021, 3(1):28.
[9] Sader N, De Lotbiniere-Bassett M, Tso M K,et al. Management of Venous Sinus Thrombosis [J]. Neurosurg Clin N Am, 2018, 29(4):585-94.
[10] Stam J. Thrombosis of the Cerebral Veins and Sinuses [J]. N Engl J Med, 2005, 352(17):1791-8.
[11] Girot M, Ferro J M, Canhao P, et al. Predictors of Outcome in Patients with Cerebral Venous Thrombosis and Intracerebral Hemorrhage [J]. Stroke, 2007, 38(2):337-42.
[12] Mineyko A, Kirton A, Billinghurst L, et al. Seizures and Outcome One Year After Neonatal and Childhood Cerebral Sinovenous Thrombosis [J]. Pediatr Neurol,2020,105:21-6.
[13] 王晗. 儿童脑静脉窦血栓临床分析 [C]. 2022.
[14] 王澎, 吉训明, 冀园琦,等. 儿童颅内静脉窦血栓形成抗凝治疗的队列研究 [J]. 中华小儿外科杂志, 2016, 037 (003):163-171.
[15] Bousser M G, Ferro J M. Cerebral Venous Thrombosis: An Update [J]. Lancet Neurol, 2007, 6(2):162-170.
[16] Piazza G. Cerebral Venous Thrombosis [J]. Circulation, 2012, 125(13):1704-1709.
[17] 李杰.脑静脉系统血栓形成的病因分析[D].河北医科大学,2023..
[18] 叶伟, 张超. 脑静脉窦血栓形成患者临床及MRI/MRV特征与抗凝治疗预后的相关性分析 [J]. 中国CT和MRI杂志, 2024, 22(01):7-10.
[19] Ferro J M, Canhao P, Stam J,et al. Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) [J]. Stroke, 2004, 35(3):664-670.
[20] Sinha R, Ramji S. Neurovascular Disorders in Children: An Updated Practical Guide [J]. Transl Pediatr, 2021, 10(4):1100-1116.
[21] 苏鑫, 李育, 蔡赛男,等. MR二维时间飞跃法、三维梯度毁损回波序列及时间分辨对比剂动态显像诊断颅内静脉窦血栓 [J]. 中国医学影像技术, 2022, 38(12):1786-1790.
[22] Ismail N, Clarke R, John C M,et al. A Study on the Distinctive Clinical Profile and Thrombophilia in Pediatric Cerebral Venous Sinus Thrombosis [J]. J Pediatr Neurosci, 2021, 16(3):225-231.
[23] Deveber G, Andrew M, Adams C,et al. Cerebral sinovenous thrombosis in children [J]. N Engl J Med, 2001, 345(6): 417-423.
[24] Sebire G, Tabarki B, Saunders D E,et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome [J]. Brain, 2005, 128(Pt 3): 477-489.
[25] Ichord R N, Benedict S L, Chan A K,et al. Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study [J]. Arch Dis Child, 2015, 100(2): 174-179.
[26] Linkins L A, Dans A L, Moores L K,et al. Treatment and Prevention of Heparin-Induced Thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(2 Suppl):e495S-e530S.
[27] Monagle P, Chan A K C, Goldenberg N A,et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(2 Suppl):e737S-e801S.
[28] Male C, Lensing A W A, Palumbo J S,et al. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial [J]. Lancet Haematol, 2020, 7(1):e18-e27.
[29] 任博文, 刘亚玲, 高琳,等. 颅内静脉窦血栓形成血管内治疗的疗效及获益分析 [J]. 国际神经病学神经外科学杂志, 2021, 48(06):516-520.
[30] Coutinho J M, Zuurbier S M, Bousser M G,et al. Effect of Endovascular Treatment with Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical Trial [J]. JAMA Neurol, 2020, 77(8): 966-973.
[31] Xu Z, Li X, Feng D,et al. Endovascular Therapy Versus Anticoagulation for Treatment of Cerebral Venous Sinus Thrombosis: A Meta-Analysis [J]. Neurologist, 2021, 27(2): 69-73.
[32] Batista S, Sanches J P B, Andreao F F,et al. Evaluating the Efficacy of Stent Retriever and Catheter Aspiration Combination in Refractory Cerebral Venous Sinus Thrombosis: A comprehensive Meta-Analysis [J]. J Clin Neurosci, 2024, 120: 154-162.
[33] Gadgil N, Aldave G, Whitehead W E,et al. Endovascular Intervention for Refractory Pediatric Cerebral Venous Sinus Thrombosis [J]. Pediatr Neurol, 2021, 121: 45-50.